Regulatory T cells (T reg) are essential for maintaining peripheral tolerance, preventing autoimmune diseases and limiting chronic inflammatory diseases.
T reg have been the focus of extensive research over the past few years, and this has revealed their role in numerous diseases, including Multiple Sclerosis(MS). MS patients have reduced functional activity of T reg.
Current research demonstrated inverse interrelation between the number of T reg and disability scale EDSS in patients with MS
One of the promising therapy options for MS is treatment with autologous regulatory T cells expanded ex vivo.
Regenex company has developed a unique technology to reach a robust ex vivo increase in number of autologous T reg in a short time .